These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
127 related articles for article (PubMed ID: 28590458)
1. Highlights in myeloproliferative neoplasms from the 2016 American Society of Hematology meeting: Commentary. Mesa RA Clin Adv Hematol Oncol; 2017 Feb; 15 Suppl 2(2):21-23. PubMed ID: 28590458 [No Abstract] [Full Text] [Related]
2. Highlights in myeloproliferative neoplasms from the 60th American Society of Hematology Annual Meeting: commentary. Mesa RA Clin Adv Hematol Oncol; 2019 Jan; 17 Suppl 2(1):18-19. PubMed ID: 31545310 [No Abstract] [Full Text] [Related]
4. [112th Scientific Meeting of the Japanese Society of Internal Medicine: Educational Lecture: Therapeutic Strategy for Myeloproliferative Neoplasms]. Nagata K; Shimoda K Nihon Naika Gakkai Zasshi; 2015 Sep; 104(9):1918-23. PubMed ID: 30160899 [No Abstract] [Full Text] [Related]
5. Highlights in myeloproliferative neoplasms from the 60th American Society of Hematology Annual Meeting. Clin Adv Hematol Oncol; 2019 Jan; 17 Suppl 2(1):1-20. PubMed ID: 31545309 [No Abstract] [Full Text] [Related]
6. [Transient myeloproliferative disorder in Down syndrome]. Ito E; Toki T Nihon Rinsho; 2012 Apr; 70 Suppl 2():687-91. PubMed ID: 23134029 [No Abstract] [Full Text] [Related]
7. American Society of Hematology--48th Annual Meeting and Exposition. Updates on hematological therapies. 9-12 December 2006 Orlando, FL, USA. Walker K IDrugs; 2007 Feb; 10(2):78-80. PubMed ID: 17285452 [No Abstract] [Full Text] [Related]
10. Myelodysplastic/myeloproliferative neoplasms: a disease in need of recognition. Khan M; Sarfraz M; Daver N Future Oncol; 2017 Jan; 13(2):117-120. PubMed ID: 27676208 [No Abstract] [Full Text] [Related]
11. Efficacy of inchinkoto for a patient with liver fibrosis complicated with transient abnormal myelopoiesis in Down's syndrome. Takeyama M; Uchida Y; Arai I; Kamamoto T; Nishikubo T; Kanehiro H; Sado T; Kunishima S; Takahashi Y Pediatr Int; 2011 Dec; 53(6):1093-6. PubMed ID: 22181572 [No Abstract] [Full Text] [Related]
12. [The cutting edge of medicine: pathophysiology and treatment of myeloproliferative neoplasms]. Komatsu N Nihon Naika Gakkai Zasshi; 2014 Feb; 103(2):440-9. PubMed ID: 24724385 [No Abstract] [Full Text] [Related]